Profil
Cidnee Vaykovich is currently a Director at ChemioCare, Inc. She was previously a Director at Pike Therapeutics, Inc. and served as the Chief Operating Officer & Secretary at Starton Therapeutics, Inc. from 2017 to 2023.
Aktive Positionen von Cidnee Vaykovich
Unternehmen | Position | Beginn |
---|---|---|
ChemioCare, Inc.
ChemioCare, Inc. Pharmaceuticals: MajorHealth Technology ChemioCare, Inc. engages in the development and manufacture of pharmaceutical products. The company was founded in 2017 and is headquartered in New York, NY. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Cidnee Vaykovich
Unternehmen | Position | Ende |
---|---|---|
Starton Therapeutics, Inc.
Starton Therapeutics, Inc. BiotechnologyHealth Technology Starton Therapeutics, Inc. is a clinical-stage biotechnology platform company that focuses on transforming standard of care therapies with proprietary continuous delivery technology. The company is based in Paramus, NJ. The company's goal is to provide continuous treatment to people with cancer so they can live better and longer. Starton's proprietary transdermal technology is intended to increase the efficacy of approved drugs, make them more tolerable, and expand their potential use. The company was founded in 2017 by Pedro Lichtinger, who has been the CEO since 2017. | Geschäftsführer | 01.02.2023 |
Pike Therapeutics, Inc.
Pike Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pike Therapeutics, Inc. operates as a pharmaceutical company . The company is headquartered in Vancouver, Canada. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
ChemioCare, Inc.
ChemioCare, Inc. Pharmaceuticals: MajorHealth Technology ChemioCare, Inc. engages in the development and manufacture of pharmaceutical products. The company was founded in 2017 and is headquartered in New York, NY. | Health Technology |
Pike Therapeutics, Inc.
Pike Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pike Therapeutics, Inc. operates as a pharmaceutical company . The company is headquartered in Vancouver, Canada. | Health Technology |
Starton Therapeutics, Inc.
Starton Therapeutics, Inc. BiotechnologyHealth Technology Starton Therapeutics, Inc. is a clinical-stage biotechnology platform company that focuses on transforming standard of care therapies with proprietary continuous delivery technology. The company is based in Paramus, NJ. The company's goal is to provide continuous treatment to people with cancer so they can live better and longer. Starton's proprietary transdermal technology is intended to increase the efficacy of approved drugs, make them more tolerable, and expand their potential use. The company was founded in 2017 by Pedro Lichtinger, who has been the CEO since 2017. | Health Technology |